KOSDAQ - Delayed Quote KRW

GemVax&KAEL Co.,Ltd (082270.KQ)

35,800.00

+2,850.00

+(8.65%)

At close: 3:30:15 PM GMT+9

Seoul National University Bundang Hospital Establishes the first "International PSP Research and Treatment Center" in Korea

Seoul National University Bundang Hospital ("SNUBH"), CurePSP, Inc. ("CurePSP") and GemVax & KAEL Co., Ltd. ("GemVax"; KOSDAQ: 082270) have announced the establishment of Korea's first International Progressive Supranuclear Palsy ("PSP") Research and Treatment Center.

PR Newswire 4 months ago

082270.KQ
+8.65%
082270.KS
GemVax Announces Topline Results from Phase 2a Progressive Supranuclear Palsy Clinical Trial at Neuro2024

GemVax & KAEL Co., Ltd. ("GemVax"; KOSDAQ ticker: 082270) announced that topline results of a Phase 2a clinical trial (the "Phase 2a PSP Clinical Trial") of GV1001, an investigational peptide drug for the treatment of progressive supranuclear palsy ("PSP"), were presented at "Neuro2024: The PSP and CBD International Research Symposium" in Toronto, Canada, at 4:45 p.m. local time on 24th October.

PR Newswire 5 months ago

082270.KQ
+8.65%
082270.KS

Performance Overview

Return	082270.KQ	KOSPI Composite Index (^KS11)
YTD	+141.89%	+5.25%
1-Year	+224.28%	-3.72%
3-Year	+146.05%	-6.62%